Hypotron

Midodrine Hydrochloride, the active ingredient in Hypotron, is an Alpha-1 adrenergic agonist presented as an oral tablet for oral use. It is employed to raise blood pressure in patients with orthostatic hypotension, helping to reduce dizziness and fainting episodes.

GNH USA supplies Hypotron as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. Global logistics are coordinated to ensure timely delivery to diverse healthcare settings.

Midodrine Hydrochloride is used to manage conditions related to low blood pressure, particularly orthostatic hypotension. - Orthostatic hypotension: Increases standing blood pressure and reduces dizziness or fainting. - Neurogenic orthostatic hypotension: Improves autonomic failure‑related blood pressure drops. - Post‑ural hypotension: Helps maintain cerebral perfusion after rapid position changes.

Midodrine Hydrochloride may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Piloerection: Goose‑skin appearance due to peripheral vasoconstriction. - Pruritus: Itching, often localized. - Urinary retention: Difficulty initiating or completing urination. - Supine hypertension: Elevated blood pressure while lying down. - Nausea: Mild gastrointestinal discomfort. - Headache: Tension‑type or throbbing pain.

Serious or Rare Side Effects: - Severe hypertension: Marked increase in blood pressure that may require emergency treatment. - Cardiac arrhythmias: Irregular heart rhythms potentially linked to blood pressure spikes. - Ischemic events: Rare cases of tissue ischemia in extremities. - Allergic reactions: Rash, swelling, or anaphylaxis.

When prescribing Midodrine Hydrochloride, clinicians should observe several safety precautions to minimize risks. - Assess baseline blood pressure: Verify that supine pressure is not excessively high before initiating therapy. - Monitor supine hypertension: Check blood pressure after lying down, especially within the first weeks. - Adjust dose in renal impairment: Reduce dosage or increase monitoring in patients with reduced kidney function. - Avoid use in severe cardiac disease: Contraindicated in uncontrolled heart failure or recent myocardial infarction. - Counsel patients on timing: Advise taking the medication during daytime and avoiding doses within four hours of bedtime. - Store at ambient temperature: Keep below 25°C in the original container, protected from moisture and light.

Midodrine Hydrochloride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): Combined use may cause excessive vasoconstriction and hypertensive crisis. - Direct vasopressors (e.g., norepinephrine): Additive blood pressure‑raising effect can lead to severe hypertension.

Moderate Interactions (Monitor Closely): - Diuretics: May potentiate orthostatic hypotension when therapy is withdrawn. - Anticholinergic agents: Can increase risk of urinary retention. - Tricyclic antidepressants: May enhance α‑adrenergic effects, requiring blood pressure monitoring. - β‑blockers: May blunt compensatory heart rate response, necessitating careful observation.